We recently discovered that the pharmacological activation of wtp53 can induce anti-cancer IFN response in cancer cell lines, mouse models and patients via de-repression of ERVs and induction of dsRNA stress, as well as facilitate anti-tumour immune cells infiltration within TME in two mouse models [23]. This evidence concerns the gene IFNA1 and neoplasm.